8-K
filed November 3, 2023, 7:59 PM ET
ticker PRVA
CIK 0001759655
earnings
confidence high
sentiment positive
materiality 0.70
Privia Health Q3 revenue $417M (+22%); net income $5.6M; raises FY guidance
Privia Health Group, Inc.
2023-Q3 EPS reported
$0.16
revenue$1,216,909,000
- Q3 rev $417.3M (+22% YoY); GAAP net income $5.6M vs $1.6M.
- Adjusted net income $21.1M ($0.17) vs $16.7M ($0.13) (+26%).
- Implemented providers 4,105 (+14%); attributed lives 1.09M (+29%).
- FY guidance raised: Platform Contribution above high end; Adj. EBITDA $70-74M.
- Entering South Carolina with Greenville ENT (20 providers); H1 2024.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Privia Health Group, Inc. reported the third quarter ended September 30, 2023 results: revenue $417.3 million, net income $5.6 million, EPS $0.05 per share.
- Period
- the third quarter ended September 30, 2023
- Revenue
- $417.3 million
- Net income
- $5.6 million
- EPS
- $0.05 per share
- Result
- reported results
Exact text from the filing
Total revenue for the third quarter of 2023 was $417.3 million, compared to total revenue of $342.9 million for the prior year third quarter (+21.7%). Gross Profit for the third quarter of 2023 was $90.6 million, compared to $76.9 million for the prior year third quarter. Operating income for the third quarter of 2023 was $5.5 million, compared to operating loss of $(4.6) million for the prior year third quarter. Net income for the third quarter of 2023 was $5.6 million, or $0.05 per share, compared to net income of $1.6 million, or $0.01 per share, for the third quarter of 2022.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Privia Health Group, Inc. reported the nine months ended September 30, 2023 results: revenue $1.22 billion, net income $20.2 million, EPS $0.16 per diluted share.
- Period
- the nine months ended September 30, 2023
- Revenue
- $1.22 billion
- Net income
- $20.2 million
- EPS
- $0.16 per diluted share
- Result
- reported results
Exact text from the filing
Total revenue was $1.22 billion for the nine months ended September 30, 2023, an increase from $992.2 million for the same period in 2022 (+22.6%). Operating income for the first nine months of 2023 was $19.2 million, compared to operating loss of $(21.4) million for the same period in 2022. Net income for the first nine months of 2023 was $20.2 million, or $0.16 per diluted share, compared to net loss of $(26.4) million, or $(0.24) per diluted share, for the same period in 2022.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.